Cost-Effectiveness Analysis Of Lurasidone And Olanzapine In The Treatment Of Schizophrenia

Autor:	Masoom Priyadarshini, JW Hay
Rok vydání:	2016
Předmět:	Olanzapine medicine.medical_specialty business.industry Health Policy Schizophrenia (object-oriented programming) Public Health Environmental and Occupational Health medicine Cost-effectiveness analysis business Psychiatry Lurasidone medicine.drug
Zdroj:	Value in Health. 19:A188-A189
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::12c514617c4f1fc19a7d4a4ff501a529 https://doi.org/10.1016/j.jval.2016.03.1380 Zobrazit plný text záznamu Full Text from ScienceDirect